Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile

Keyphrases

• Acutely Ill Patients 25%
• Ambulatory Patients 50%
• Ambulatory Pediatrics 100%
• Automated Blood Culture 25%
• Bacteremia 25%
• Blood Culture 50%
• Cefepime 25%
• Chile 25%
• Developed Countries 25%
• Disease Incidence 25%
• Emergency Patients 25%
• Emergency Room 100%
• Fatality 25%
• Health Authorities 50%
• High Fever 100%
• High-level Resistance 25%
• Hospitalized children 25%
• In(III) 25%
• Invasive Pneumococcal Disease 100%
• Pediatric 75%
• Penicillin 25%
• Pneumococcal Bacteremia 25%
• Pneumococcal Conjugate Vaccine 50%
• Pneumococcal Disease 75%
• Pneumococcal Isolates 25%
• Population-based Surveillance 100%
• Primary Care Services 25%
• S. Pneumoniae 25%
• Santiago De Chile 100%
• Serogroup 25%
• Streptococcus Pneumoniae 25%
• Vaccine Serotypes 25%

Medicine and Dentistry

• Bacteremia 50%
• Blood Culture 75%
• Case Fatality Rate 25%
• Cefotaxime 25%
• Disease 75%
• High Fever 100%
• Morbidity 25%
• Outpatient 50%
• Pediatrics 100%
• Penicillin Derivative 25%
• Pneumococcal Infection 100%
• Pneumococcus 25%
• Pneumococcus Vaccine 50%
• Primary Health Care 25%
• Serotype 100%
• Streptococcus Pneumoniae 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Bacteremia 66%
• Case Fatality Rate 33%
• Cefotaxime 33%
• Disease 100%
• Morbidity 33%
• Penicillin Derivative 33%
• Pneumococcal Infection 100%
• Pneumococcus Vaccine 66%
• Streptococcus Pneumoniae 33%